Voyageur Pharmaceuticals Ltd VYYRF

Primary Symbol: V.VM

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Endohedral Fullerene $167,000,000/gram

<< Previous

Bullboard Posts

Next >>

Comment by postie1on Jun 07, 2024 12:58pm

110 Views

Post# 36077926

RE:Endohedral Fullerene $167,000,000/gram

Just for the record, the last sale for VM was at .08 but is being hidden on the
dark boards(manipulation ?)

And stuff like this is why I am of the belief that VM has a big target on its' back and there will be a buyout attempt before things get moving along too far..How much are VMs licences alone worth plus the deposit. I am taking a guess that it is more than what the market is valuing VM at!

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages